Major League Baseball drug policy

Major League Baseball's drug policy—the Joint Drug Prevention and Treatment Program—was established by agreement between the MLB Players Association and the Office of the Commissioner of Baseball. The goal was to deter and end the use of banned substances, including anabolic steroids and other illegal drugs, and to "provide for, in keeping with the overall purposes of the Program, an orderly, systematic, and cooperative resolution of any disputes that may arise concerning the existence, interpretation, or application" of the policy itself. The Joint Drug Prevention and Treatment Program was adopted in the Spring of 2006.

While the Health Policy Advisory Committee (HPAC) can make recommendations to the Office of the Commissioner regarding punishment, it has no power to discipline players for violations of the drug policy, except to place them in the appropriate treatment programs. Such authority belongs to the Office of the Commissioner.

Prohibited substances

Main article: List of banned substances in baseball

Under the policy, all players are prohibited from using, possessing, selling, facilitating the sale of, distributing, or facilitating the distribution of any Drug of Abuse, human growth hormone (HGH) and steroid. Any and all drugs or substances listed under Schedule II of the Controlled Substances Act are considered drugs of abuse covered by the Program. Players who require prescription medication can still use it with a "Therapeutic Use Exemption" granted by MLB.

Prohibited Substances may be added to the list only by the unanimous vote of HPAC, provided that the addition by the federal government of a substance to Schedule I, II, or III will automatically result in that substance being added to the list.

Testing for banned substances

Steroids

Testing is administered via scientifically-validated urine test.

Each Player shall be tested upon reporting to spring training. All Players will be selected for an additional unannounced urine specimen collection during the season on a randomly selected date.

Drugs of abuse

Testing for drugs of abuse is not administered randomly, but on a basis of reasonable cause. If one of the HPAC panel members has evidence that a player has used, possessed, or sold banned substances in the last 12 months, they call a conference and discuss the evidence with the other members. If a majority vote to test the suspected player is reached then testing will take place no more than 48 hours later. Drugs of abuse include natural cannabinoids (e.g., THC, hashish and marijuana), synthetic THC and cannabimimetics (e.g., K2 and Spice), cocaine, LSD, opiates (e.g., oxycodone, heroin, codeine, and morphine), MDMA (ecstasy), GHB and phencyclidine (PCP).

Testing procedure

Players and the collector must instruct the player to return in an hour, during which he can only drink 15 oz. of fluid in a sealed container(s) certified by the collector.

Testing protocols

Any test conducted under the Program will be considered "positive" under the following circumstances:

1. If any substance identified in the test results meets the levels set forth below.
2. A Player refuses or, without good cause, fails to take a test or refuses to cooperate with the testing process.
3. A Player attempts to substitute, dilute, mask or adulterate a specimen sample or in any other manner alter a test.

Drugs of abuse

Drug	Initial Test Level (ng/mL)	Confirmation Test Level (ng/mL)
Cocaine Metabolites	300	150
Opiates/Metabolites	2000	2000
Phencyclicdine (PCP)	25	25
Cannabinoids	50	15

Steroids

A test is considered positive if a sufficient amount of Steroid is present, except the presence of nandrolone, which is considered positive only if the level exceeds 2 ng/ml.

Stimulants

The presence of a Stimulant shall be considered a positive only if the level exceeds 250 ng/ml, unless specified otherwise below:

Drug	Confirmation Test Level (ng/mL)
Amfepramone (Diethylproprion)	500
Amphetaminil	2000
Chlorphentermine	500
Clortermine	500
Ephedrine	10
Methylphenidate	1000
Phenpentermine	1000
Phentermine	500

Notification

HPAC immediately notifies the Player and the Club of the positive drug test result.

In-Season testing

On January 10, 2013, MLB and the players union reached an agreement to add random, in-season human growth hormone and to a new test to reveal the use of testosterone. Testing began the 2013 season.

Clinical and administrative tracks

All players who enter the program are placed on the Clinical track, except when a player tests positive for steroids, does not comply with the initial evaluation, cooperate in his treatment, is convicted or pleads guilty or nolo contendere to the sale or use and prohibited substance, or participates in the sale or distribution of any banned substance. In that event, the player is placed in the Administrative Track. HPAC has the discretion to place a player in the Administrative Track in any other event, but not solely on the basis that the player is in an inpatient treatment program. Transfer to the Administrative track is contingent on a majority vote, and in the case of a tie, a fifth member must cast a vote based on reasonable cause and cannot consider past practice. These votes are tallied and set forth in progressing games

Salary retention

Players are entitled to salary retention for the first 30 days they are required to be in inpatient treatment or outpatient treatment that forces his absence from the Club, and half salary retention for the next thirty days, over the course of his career. However, players are not entitled to salary retention for any such period after 60 days during the course of his career.

Player evaluations

Players are required to be evaluated at least once by HPAC, to determine the proper treatment program. HPAC may decide that additional meetings and medical and/or toxicology examinations are required.

Confidentiality

The Office of the Commissioner, the Association, HPAC, Club personnel, and all of their members, affiliates, agents, consultants and employees, are prohibited from publicly disclosing information about the Player's test results, Initial Evaluation, diagnosis, Treatment Program (including whether a Player is on either the Clinical or Administrative Track), prognosis or compliance with the Program.

Discipline

Failure to comply with treatment program

• First failure to comply: 15- to 25-day suspension and/or a fine of up to $10,000
• Second failure to comply: 25- to 50-day suspension and/or a fine of up to $25,000
• Third failure to comply: 50- to 75-day suspension and/or a fine of up to $50,000
• Fourth failure to comply: minimum one-year suspension and/or a fine of up to $100,000
• Any subsequent failure(s) to comply: The level of the discipline will be determined by the Office of the Commissioner, consistent with the concept of progressive discipline.

All suspensions are without pay.

Positive steroid test results

See also: List of Major League Baseball players suspended for performance-enhancing drugs

• First positive test result: 80 game suspension
• Second positive test result: 162 game suspension (the entire season, including the postseason)
• Third positive test result: lifetime ban from MLB
• All suspensions are without pay. In addition, a suspended player can be replaced on the active roster by another player. If a player is on the injured list, the suspension is served while on the injured list. Unless a suspension is reduced on appeal, a suspended player is not eligible to participate in that year's postseason even if his suspension ends before then.
• Players who test positive for either their first or second tests are given the option to appeal, in which scientific tests will be conducted to prove validity of test. Within that period of time, they are restricted from participation in all baseball activity. If an appeal is successful, the suspension may be reduced by 40 games for the first offense or 80 games for the second offense. The postseason ban is also lifted. There is no appeal for a third offense.
• Players who receive a lifetime ban after a third positive test may apply for reinstatement after one year and be eligible to be reinstated after two years. Jenrry Mejía became the only player to be permanently banned under the drug policy on February 12, 2016.

Conviction for use of prohibited substances

• First offense: 15- to 30-day suspension and/or a fine of up to $10,000
• Second offense: 30- to 90-day suspension and/or a fine of up to $50,000
• Third offense: minimum one-year suspension and/or a fine of up to $100,000
• Fourth offense: minimum two-year suspension
• Any subsequent offense(s): The level of the discipline will be determined by the Office of the Commissioner, consistent with the concept of progressive discipline.

All suspensions are without pay.

See also

• List of Major League Baseball players suspended for performance-enhancing drugs

External links

• Major League Baseball's Joint Drug Prevention and Treatment Program